Vanda Pharmaceuticals (VNDA) Other financing activities (2010 - 2022)

Vanda Pharmaceuticals (VNDA) has 10 years of Other financing activities data on file, last reported at $571000.0 in Q4 2022.

• For the quarter ending Q4 2022, Other financing activities fell 47.66% year-over-year to $571000.0; the trailing twelve-month figure through Dec 2023 stood at $575000.0 (down 17.86% YoY), and the FY2022 full-year result was $700000.0, down 80.56% from the prior year.
• Other financing activities climbed to $571000.0 in Q4 2022, from $4000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $3.6 million in Q2 2020 to a low of $4000.0 in Q3 2022.
• A 5-year average of $1.2 million and a median of $571000.0 in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities jumped 481.54% in 2018 and tumbled 98.92% in 2022, its largest moves.
• Tracing VNDA's Other financing activities over 5 years: stood at $756000.0 in 2018, then jumped by 184.66% to $2.2 million in 2019, then sank by 33.46% to $1.4 million in 2020, then slipped by 23.81% to $1.1 million in 2021, then plunged by 47.66% to $571000.0 in 2022.
• Business Quant data shows VNDA's Other financing activities at $571000.0 in Q4 2022, $4000.0 in Q3 2022, and $125000.0 in Q2 2022.